EN
中文 EN
OncoScreen® Heme is a comprehensive genomic profiling panel designed for patients with hematologic malignancies.
It enables capture-based targeted sequencing of both DNA and RNA from a single sample, providing a streamlined and integrated testing solution.
Key Features and Benefits

Comprehensive Genomic Profiling Panel


569 DNA genes
322 RNA Genes
OncoScreen® HEME combines DNA and RNA sequencing to detect all four main classes of genomic alterations, including SNV, InDel, SV (Fusion / ITD / PTD), CNV





Focus on Hematologic Malignancies


Covering the guideline-recommended biomarkers in hematologic malignancies: Leukemia (AML, ALL, CML, CLL); Lymphoma; Multiple Myeloma; Myelodysplastic Syndrome (MDS); Myeloproliferative Neoplasms (MPN).




Compatible with Multiple Sample Types


Peripheral blood (PB), Bone Marrow Aspirate (BMA), or FFPE Tissue.



Performance Validations
Applicable for Multiple Indications with Exceptional Performance



DNA for calling SNVs / Indels / Fusions / CNVs / ITDs: LoD as low as 1% AF.

RNA for calling Fusions / ITDs / PTDs: LoD as low as 10 copies/ng.



Download Our Product Brochure Here Contact Us
Contact Our Biopharma Team to Learn More
Biomarker Discovery & Translational Research
Clinical Trial Design & Patient Recruitment
Global Capabilities for Clinical Studies
CDx Development & Commercialization
Genomic Data Solutions
ctDNA Monitoring Portfolio
Other
I also want to receive general marketing communications from Burning Rock Dx in addition to the specific information requested here. You may unsubscribe from receiving such general marketing communications at any time.
*Required
By submitting this form, or by checking the box above the “Submit” button (if applicable), you agree that your information will be processed according to Burning Rock’s privacy policy to provide you with the information and/or general marketing communications (if applicable) you have requested here. Burning Rock Dx is committed to protecting and respecting your privacy.
Contact Our Experts
We would like to collect certain personal information about you through cookies and similar technologies in order to personalize the site for you, improve the performance of the site, and support our marketing efforts. By clicking “Accept All”, you confirm that we have your consent to collect and process your personal information in accordance with our Privacy Policy, which may include online targeted and social media advertising in some instances. You can by clicking “Reject All”, you can reject all cookies except for Strictly Necessary Cookies."